Many ques­tions, few an­swers in Sen­ate hear­ing on opaque US drug pric­ing sys­tem

The Sen­ate Health, Ed­u­ca­tion, La­bor & Pen­sions com­mit­tee on Tues­day dis­cussed with rep­re­sen­ta­tives of the phar­ma­ceu­ti­cal sup­ply chain how the drug de­liv­ery sys­tem af­fects what pa­tients pay.

Al­though none of the com­ments and ar­gu­ments for re­duc­ing the price of phar­ma­ceu­ti­cals were new, pan­elists and sen­a­tors even seemed to dis­agree on what ex­act­ly is caus­ing prices in the US to be so much high­er than the rest of the world.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER